Safety Study of Roflumilast Cream 0.05% in Infants Aged 3 Months to Less Than 2 Years With Atopic Dermatitis
Clinical trial NCT06998056 · COMPLETED
Trial details
- NCT number
- NCT06998056
- Sponsor
- Arcutis Biotherapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-09
- Primary completion
- 2025-12-04
- Enrollment
- 101
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.